Cyclacel Pharmaceuticals, Inc. - Common Stock (CYCC)
0.3405
-0.0179 (-4.99%)
Cyclacel Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of innovative cancer therapies
The company leverages its proprietary drug development programs, which aim to address unmet medical needs in oncology, by targeting specific cancer cell cycle mechanisms and pathways. With a strong emphasis on research and development, Cyclacel is engaged in advancing its pipeline of therapeutic candidates towards clinical trials, seeking to bring new treatment options to patients with various types of cancer. Through its scientific expertise, the company strives to improve patient outcomes and contribute to the advancement of cancer care.
Frequently Asked Questions
Is Cyclacel Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Cyclacel Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Cyclacel Pharmaceuticals, Inc. - Common Stock trade on?
Cyclacel Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Cyclacel Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Cyclacel Pharmaceuticals, Inc. - Common Stock is CYCC on the Nasdaq Stock Market
What is the current price of Cyclacel Pharmaceuticals, Inc. - Common Stock?
The current price of Cyclacel Pharmaceuticals, Inc. - Common Stock is 0.3405
When was Cyclacel Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Cyclacel Pharmaceuticals, Inc. - Common Stock was at 1:43 pm EST on January 31st, 2025
What is the market capitalization of Cyclacel Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Cyclacel Pharmaceuticals, Inc. - Common Stock is 2.14M
How many shares of Cyclacel Pharmaceuticals, Inc. - Common Stock are outstanding?
Cyclacel Pharmaceuticals, Inc. - Common Stock has 6.29M shares outstanding.